ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,445.80
0.21%
Dow Jones
39,839.26
0.71%
Gold vs US Dollar
2,384.31
1.23%
Brent Oil
82.61
0.07%
Bitcoin
65,329.34
6.15%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Organovo Holdings Inc (ONVO)

  7. Organovo Holdings Inc (ONVO) News

Organovo (ONVO)

Organovo Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ONVO
DateTimeSourceHeadlineSymbolCompany
14/05/202417:45Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ONVOOrganovo Holdings Inc
14/05/202416:00GlobeNewswire Inc.Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)NASDAQ:ONVOOrganovo Holdings Inc
13/05/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONVOOrganovo Holdings Inc
10/05/202422:15Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ONVOOrganovo Holdings Inc
09/05/202401:00GlobeNewswire Inc.Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public OfferingNASDAQ:ONVOOrganovo Holdings Inc
15/04/202413:05GlobeNewswire Inc.Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to PlaceboNASDAQ:ONVOOrganovo Holdings Inc
09/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ONVOOrganovo Holdings Inc
08/02/202421:56Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ONVOOrganovo Holdings Inc
08/02/202421:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONVOOrganovo Holdings Inc
07/02/202413:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONVOOrganovo Holdings Inc
26/01/202422:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ONVOOrganovo Holdings Inc
25/01/202413:05GlobeNewswire Inc.Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis CongressNASDAQ:ONVOOrganovo Holdings Inc
09/01/202413:05GlobeNewswire Inc.Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis CongressNASDAQ:ONVOOrganovo Holdings Inc
28/12/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONVOOrganovo Holdings Inc
22/12/202311:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ONVOOrganovo Holdings Inc
06/12/202313:05GlobeNewswire Inc.Organovo Provides Timing for Release of FXR314 Phase 2 NASH ResultsNASDAQ:ONVOOrganovo Holdings Inc
01/12/202321:07Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ONVOOrganovo Holdings Inc
17/11/202323:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
17/11/202323:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
17/11/202323:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
17/11/202323:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
17/11/202323:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
15/11/202321:41Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ONVOOrganovo Holdings Inc
13/11/202313:05GlobeNewswire Inc.CORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and PlanNASDAQ:ONVOOrganovo Holdings Inc
09/11/202322:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONVOOrganovo Holdings Inc
08/11/202313:05GlobeNewswire Inc.Organovo Highlights FXR314 Combination Therapy Potential and PlanNASDAQ:ONVOOrganovo Holdings Inc
03/11/202312:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONVOOrganovo Holdings Inc
22/09/202321:05Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ONVOOrganovo Holdings Inc
13/09/202322:07Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ONVOOrganovo Holdings Inc
13/09/202322:06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ONVOOrganovo Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:ONVO

Your Recent History

NASDAQ
RCIBX
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved